Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial - Concepedia

Concepedia

Publication | Open Access

Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial

DOI Full Paper Access

57

Citations

23

References

2024

Year

Heinz‐Josef Lenz, Aparna R. Parikh, David R. Spigel, Allen Lee Cohn, Takayuki Yoshino, Mark D. Kochenderfer, Élena Elez, Spencer H. Shao, Dustin A. Deming, Regan Holdridge,

Journal for ImmunoTherapy of Cancer

Abstract

NCT03414983.

References

	Year	Citations

Page 1